In this article the author, who was the first director of the Special Action Office for Drug Abuse Prevention, looks at changes during the last decade in American approaches to dealing with problems of drug abuse and the treatment of drug abusers.
Get full access to this article
View all access options for this article.
References
1.
BourneP.G.1976“How Much Treatment Is Enough?”Washington Drug Review1(3): 6–7.
2.
DoleV.P.NyswanderM.E.1965“A Medical Treatment for Diacetylmorphine (heroin) Addiction.”JAMA193:646–650.
DoleV.P.NyswanderM.E.1976“Methadone Maintenance Treatment: A Ten-Year Perspective.”JAMA235:2117–2119.
5.
DuvallH.J.LockeB.BrillL.1963“Follow-Up Study of Narcotic Drug Addicts Five Years After Hospitalization.”Publ. Hlth Rep., Wash. 78:185–193.
6.
Federal Strategy for Drug Abuse and Drug Traffic Prevention. 1973Washington, D.C.: U.S. Government Printing Office.
7.
Federal Strategy for Drug Abuse and Drug Traffic Prevention. 1974Washington, D.C.: U.S. Government Printing Office.
8.
Federal Strategy for Drug Abuse and Drug Traffic Prevention. 1975Washington, D.C.: U.S. Government Printing Office.
9.
GearingF.R.1971Testimony in, Narcotics Research, Rehabilitation and Treatment. Hearings before the Select Committee on Crime, House of Representatives, 92nd Congress, First Session. Part I. Washington, D.C.: U.S. Government Printing Office.
10.
GoldsteinA.1972“Heroin Addiction and the Role of Methadone in its Treatment.”Archs Gen. Psychiat.26(4): 291–297.
11.
GoldsteinA.1976“Opioid Peptides (endorphins) in Pituitary and Brain.”Science193:1081–1086.
12.
GoodwinD.1976Is Alcoholism Hereditary?Oxford University Press.
13.
JaffeJ.H.1966“Research on Newer Methods of Treatment of Drug Dependent Indivduals in the U.S.A.”Proceedings of the Vth International Congress of the Collegium Internationale Neuropsychopharmacologicum. Amsterdam: Excerpta Medical International Congress Series 129:271–276.
14.
JaffeJ.H.ZacksM.S.WashingtonE.N.1969“Experience With the Use of Methadone in a Multimodality Program for the Treatment of Narcotics Users. Int. J. Addict.4:481–490.
15.
JaffeJ.H.1971Testimony in, Drug Abuse Prevention and Control. Joint hearings before the Subcommittee on Executive Reorganization and Government Research and the Subcommittee on Intergovernmental Relations of the Committee on Government Operations, United States Senate, 92nd Congress, First Session, on S.1945 and S.2097, July 1971, U.S. Government Printing Office, Washington, D.C.
16.
KurlandA.S.WurmserL.KermanF.KokoskiR.1966“Urine Detection Tests in the Management of the Narcotic Addict.”Am J. Psychiat.122:737–742.
17.
MartinW.R.GorodestskyC.W.McClaneT.K.1966“An Experimental Study in the Treatment of Narcotic Addicts with Cyclazocine.”Clin. Pharmac. Ther.7:455–465.
18.
MartinW.R.JasinskiD.R.HaertzenC.A.KayD.C.JonesB.E.ManskyP.A.CarpenterR.W.1973“Methadone—A Reevaluation.”Archs gen Psychiat.28:286–295.
19.
MartinW.R.JasinskiD.R.ManskyP.A.1973“Naltrexone, an Antagonist for the Treatment of Heroin Dependence.”Archs gen Psychiat.28:784–791.
20.
National Commission on Marihuana and Drug Abuse. 1972First Report: Marihuana: A Signal of Misunderstanding. Washington, D.C.: U.S. Government Printing Office.
21.
National Commission on Marihuana and Drug Abuse. 1973Second Report. Drug Use in America: Problem in Perspective. Washington, D.C.: U.S. Government Printing Office.
22.
National Institute on Drug Abuse. 1976Heroin Indicators Trend Report. U.S. Department of Health Education & Welfare, Publ. No. (ADM) 76–315, Washington, D.C.
23.
O'DonnellJ.A.VossH.L.ClaytonR.R.SlatinG.T.RoomR.G.W.1976Young Men and Drugs—a Nationwide Survey. NIDA Research Monograph 5, National Institute on Drug Abuse, Rockville, Md., Washington, D.C.: February. U.S. Department of Health Education & Welfare Publ. No. (ADM) 76–311:1–76.
24.
RobinsL.1974The Vietnam Drug User Returns: Final Report, Sept. 1973 Special Action Office Monograph, Ser. A., No. 2, Washington, D.C.: U.S. Government Printing Office.
25.
SnyderS.H.1975“Opiate Receptor in Normal and Drug Altered Brain Function.”Nature257:185–189.
26.
Special Action Office for Drug Abuse Prevention. 1973First Annual Report, 1973. Washington, D.C.
27.
Washington Drug Review19761(3), Washington, D.C.
28.
Washington Drug Review1975White Paper on Drug Abuse: A Report to the President from the Domestic Council Drug Abuse Task Force, September. Washington, D.C.: U.S. Government Printing Office.
